Research predicts cancer patients' response to chemotherapy agent cisplatin

by Cleveland ClinicVisual representation of convergent evolution in animals and convergent phenotypes in tumors.aBirds and bats are genomically disparate, but both have individually e

Updated on: January 30,2024 15

Research predicts cancer patients' response to chemotherapy agent cisplatin

by Cleveland ClinicVisual representation of convergent evolution in animals and convergent phenotypes in tumors.aBirds and bats are genomically disparate, but both have individually e

Updated on:January 30,2024 15

New prostate cancer biomarkers provide hope to millions of men

byUniversity of South AustraliaCredit: AI-generated imageUniSA researchers have identified three new biomarkers for prostate cancer to help identify and differentiate potentially aggressive case

Updated on: January 12,2024 10

New prostate cancer biomarkers provide hope to millions of men

byUniversity of South AustraliaCredit: AI-generated imageUniSA researchers have identified three new biomarkers for prostate cancer to help identify and differentiate potentially aggressive case

Updated on:January 12,2024 10

The long-term financial toll of breast cancer

by Johns Hopkins University Bloomberg School of Public HealthMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainThe financial fallout from breast can

Updated on: March 01,2024 12

The long-term financial toll of breast cancer

by Johns Hopkins University Bloomberg School of Public HealthMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainThe financial fallout from breast can

Updated on:March 01,2024 12

Altered cell behavior behind resistance in neuroblastoma

byLund UniversityEstablishment and application of a COJEC-like treatment protocol using NB PDX models.(A) Schematic representation of the experimental design. Mice were injected subcutaneously (

Updated on: January 04,2024 6

Altered cell behavior behind resistance in neuroblastoma

byLund UniversityEstablishment and application of a COJEC-like treatment protocol using NB PDX models.(A) Schematic representation of the experimental design. Mice were injected subcutaneously (

Updated on:January 04,2024 6

Disruption of immune cells in blood is linked to cancer outcomes, new tool reveals

Updated on: April 29,2025 0

Disruption of immune cells in blood is linked to cancer outcomes, new tool reveals

Updated on:April 29,2025 0

Illuminating tumor cells with dark proteins

by Columbia UniversityRibosome roadblock effect: comparing the AMD1 tail sequence, poly(A) and the XBP1 stalling sequence. a–e, Reporter constructs shown on the left were transfected into HEK293T

Updated on: February 19,2024 10

Illuminating tumor cells with dark proteins

by Columbia UniversityRibosome roadblock effect: comparing the AMD1 tail sequence, poly(A) and the XBP1 stalling sequence. a–e, Reporter constructs shown on the left were transfected into HEK293T

Updated on:February 19,2024 10

A comprehensive proteogenomic dataset to help cancer researchers unravel molecular mysteries

by National Institutes of HealthTumor types and data types of the CPTAC pan-cancer dataset. Overview of the available molecular data types for the CPTAC pan-cancer cohort (n= 1072, see Tabl

Updated on: February 20,2024 12

A comprehensive proteogenomic dataset to help cancer researchers unravel molecular mysteries

by National Institutes of HealthTumor types and data types of the CPTAC pan-cancer dataset. Overview of the available molecular data types for the CPTAC pan-cancer cohort (n= 1072, see Tabl

Updated on:February 20,2024 12

A sustainable diagnosis tool for multiple cancers

byNature Publishing GroupValidation via cancers diagnosis. Credit:Nature Sustainability(2024). DOI: 10.1038/s41893-024-01323-9An accurate, affordable, environmentally and user-friend

Updated on: April 28,2024 0

A sustainable diagnosis tool for multiple cancers

byNature Publishing GroupValidation via cancers diagnosis. Credit:Nature Sustainability(2024). DOI: 10.1038/s41893-024-01323-9An accurate, affordable, environmentally and user-friend

Updated on:April 28,2024 0

Triple-drug therapy for post-transplant management of multiple myeloma

by University of Chicago Medical CenterCredit: Unsplash/CC0 Public DomainResearchers from the University of Chicago Medicine Comprehensive Cancer Center and colleagues in Poland report promising

Updated on: February 18,2024 19

Triple-drug therapy for post-transplant management of multiple myeloma

by University of Chicago Medical CenterCredit: Unsplash/CC0 Public DomainResearchers from the University of Chicago Medicine Comprehensive Cancer Center and colleagues in Poland report promising

Updated on:February 18,2024 19

Family-focused interventions for African Americans with cancer

by Amy Cherry,University of DelawareCredit: Pixabay/CC0 Public DomainThe moment you're told the dreaded words: "You have cancer," your life changes forever. A parent diagnosed with

Updated on: April 28,2024 0

Family-focused interventions for African Americans with cancer

by Amy Cherry,University of DelawareCredit: Pixabay/CC0 Public DomainThe moment you're told the dreaded words: "You have cancer," your life changes forever. A parent diagnosed with

Updated on:April 28,2024 0

Testosterone therapy may protect against breast cancer in trans masculine individuals

by Jacqueline Mitchell,Beth Israel Deaconess Medical Centera) Lobular atrophy was assessed by the pathologists using four categories. b) The duration of testosterone therapy (TT) significantly c

Updated on: August 03,2024 0

Testosterone therapy may protect against breast cancer in trans masculine individuals

by Jacqueline Mitchell,Beth Israel Deaconess Medical Centera) Lobular atrophy was assessed by the pathologists using four categories. b) The duration of testosterone therapy (TT) significantly c

Updated on:August 03,2024 0

ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin

Updated on: March 30,2024 14

ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin

Updated on:March 30,2024 14